CastleKeep Investment Advisors
MDT icon

CastleKeep Investment Advisors’s Medtronic MDT Stock Holding History

CastleKeep Investment Advisors’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$926K Sell
11,834
-848
-7% -$68.4K 0.46% 49
2026
Q1 		$1.1M Buy
12,682
+2,270
+22% +$217K 0.6% 39
2025
Q4 		$1M Sell
10,412
-144
-1% -$14K 0.45% 62
2025
Q3 		$1.01M Sell
10,556
-3,681
-26% -$338K 0.47% 59
2025
Q2 		$1.24M Buy
14,237
+549
+4% +$46.6K 0.61% 55
2025
Q1 		$1.23M Sell
13,688
-627
-4% -$56.1K 0.63% 56
2024
Q4 		$1.14M Buy
14,315
+51
+0.4% +$4.42K 0.8% 52
2024
Q3 		$1.28M Buy
14,264
+1,734
+14% +$146K 0.88% 25
2024
Q2 		$986K Sell
12,530
-38
-0.3% -$3.12K 0.76% 39
2024
Q1 		$1.1M Sell
12,568
-1,494
-11% -$128K 0.79% 35
2023
Q4 		$1.16M Buy
+14,062
New +$1.07M 0.82% 31

Other funds holding MDT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

CastleKeep Investment Advisors's MDT Position: Q2 2026 in Review

CastleKeep Investment Advisors reduced its Medtronic (MDT) stake by 6.7% in Q2 2026, selling an estimated $68.4K and leaving 11,834 shares worth $926K. The position accounts for 0.46% of the portfolio, ranked #49.

CastleKeep Investment Advisors first reported a position in MDT in Q4 2023 and has held it in 11 quarters since. The position peaked at $1.28M in Q3 2024. 2,134 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • CastleKeep Investment Advisors held 11,834 shares of Medtronic worth $926K as of Q2 2026.
  • CastleKeep Investment Advisors sold 848 Medtronic shares in Q2 2026, an estimated $68.4K.
  • Medtronic made up 0.46% of CastleKeep Investment Advisors's portfolio in Q2 2026, its #49 holding.
  • CastleKeep Investment Advisors first reported a position in Medtronic in Q4 2023 and has held it in 11 quarters since.
  • CastleKeep Investment Advisors's Medtronic position peaked at $1.28M in Q3 2024.
  • 2,134 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on CastleKeep Investment Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.